MegaPro Biomedical Co., Ltd (TPEX:6827)
Taiwan · Delayed Price · Currency is TWD 10.45
-1.00 (-8.73%)
Sep 8, 2026, 1:52 PM CST
MegaPro Biomedical Market Cap
MegaPro Biomedical has a market cap or net worth of 741.05 million as of September 4, 2026. Its market cap has decreased by -32.25% in one year.
Market Cap
741.05M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10.45
ChartMarket Cap Chart
Since October 19, 2021, MegaPro Biomedical's market cap has decreased from 2.11B to 741.05M, a decrease of -64.93%. That is a compound annual growth rate of -19.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 698.99M | -13.25% |
| Dec 31, 2025 | 805.78M | -14.43% |
| Dec 31, 2024 | 941.69M | -32.75% |
| Dec 29, 2023 | 1.40B | 24.04% |
| Dec 30, 2022 | 1.13B | -38.43% |
| Dec 30, 2021 | 1.83B | -13.24% |
| Oct 19, 2021 | 2.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 955.21M |
| TCI GENE | 940.60M |
| NatureWise Biotech & Medicals | 906.14M |
| Meribank Biotech | 854.19M |
| Neith | 793.51M |
| BioLASCO Taiwan | 729.94M |
| Lukas Biomedical | 728.61M |
| Taiwan Advance Bio-Pharmaceutical | 671.40M |